Antimicrobial resistance : What does medicine quality have to do with it ?
暂无分享,去创建一个
[1] A. Attaran,et al. Poor-Quality Drugs and Global Trade: A Pilot Study , 2014, American Journal of Health Economics.
[2] P. Newton,et al. A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better , 2015, The American journal of tropical medicine and hygiene.
[3] Act Consortium Drug Quality Project Team And The I. Quality of Artemisinin-Containing Antimalarials in Tanzania's Private Sector—Results from a Nationally Representative Outlet Survey , 2015, The American journal of tropical medicine and hygiene.
[4] A. Attaran. Stopping Murder by Medicine: Introducing the Model Law on Medicine Crime , 2015, The American journal of tropical medicine and hygiene.
[5] Matthew E. Falagas,et al. Substandard/Counterfeit Antimicrobial Drugs , 2015, Clinical Microbiology Reviews.
[6] J. Roberts,et al. Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development , 2015, Seminars in Respiratory and Critical Care Medicine.
[7] S. Bagcchi. Indian generic drugs debate heats up , 2014, The Lancet.
[8] I. Choonara,et al. Quality of medicines in Canada: a retrospective review of risk communication documents (2005–2013) , 2014, BMJ Open.
[9] F. Schifano,et al. A systematic review of counterfeit and substandard medicines in field quality surveys , 2014 .
[10] P. Newton,et al. Falsified medicines in Africa: all talk, no action. , 2014, The Lancet. Global health.
[11] A. Stergachis,et al. Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries , 2014, PloS one.
[12] Laura Krech,et al. Cambodian Ministry of Health Takes Decisive Actions in the Fight Against Substandard and Counterfeit Medicines , 2014 .
[13] Atholl Johnston,et al. Substandard drugs: a potential crisis for public health , 2013, British journal of clinical pharmacology.
[14] Imti Choonara,et al. Substandard and counterfeit medicines: a systematic review of the literature , 2013, BMJ Open.
[15] I. Choonara,et al. Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011) , 2013, BMJ Open.
[16] C. Chaccour,et al. Travel and fake artesunate: a risky business , 2012, The Lancet.
[17] P. Toutain,et al. Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations. , 2011, The Journal of antimicrobial chemotherapy.
[18] Paul N. Newton,et al. Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries. , 2011, The Analyst.
[19] R. Jeffery,et al. Trust and the regulation of pharmaceuticals: South Asia in a globalised world , 2011, Globalization and health.
[20] G. Jin,et al. Does Price Reveal Poor-Quality Drugs? Evidence from 17 Countries , 2011, Journal of health economics.
[21] R. Malpani,et al. Eye on the Ball: Medicine regulation - not IP enforcement - can best deliver quality medicine , 2011 .
[22] E. Johansson,et al. Antibiotic use, resistance development and environmental factors: a qualitative study among healthcare professionals in Orissa, India , 2010, BMC public health.
[23] R. Maude,et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance , 2009, Malaria Journal.
[24] M. Rowland,et al. Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003 , 2009, Emerging infectious diseases.
[25] Janet Bumpas,et al. Exploratory Study on Active Pharmaceutical Ingredient Manufacturing for Essential Medicines , 2009 .
[26] Christina Y Hampton,et al. A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR – implications for therapeutic failure and drug resistance , 2009, Malaria Journal.
[27] Roger Bate,et al. Pilot Study Comparing Technologies to Test for Substandard Drugs in Field Settings , 2009 .
[28] N. Ford,et al. Substandard medicines in resource‐poor settings: a problem that can no longer be ignored , 2008, Tropical medicine & international health : TM & IH.
[29] P. Newton,et al. Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether. , 2008, The American journal of tropical medicine and hygiene.
[30] K. Stȩpniewska,et al. Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug Resistance , 2008, Antimicrobial Agents and Chemotherapy.
[31] O. Shakoor,et al. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies , 2001, The Lancet.
[32] P. Ringwald,et al. False chloroquine resistance in Africa , 1997, The Lancet.
[33] F. Baquero,et al. Strategies to minimize the development of antibiotic resistance. , 1997, Journal of chemotherapy.
[34] M. Kron. Substandard primaquine phosphate for US Peace Corps personnel , 1996, The Lancet.